Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HIV & AIDS Health Center

Font Size

Drug Strategy Won't Stop HIV Resistance

Interrupting Drug Treatment Won't Outwit Drug-Resistant AIDS Virus
WebMD Health News

Aug. 27, 2003 -- A strategy called structured treatment interruption (STI) won't outwit drug-resistant HIV, a new study shows.

The finding crushes hope for a bold plan to help patients for whom all existing anti-HIV drugs are failing. The idea was to extend the life of these drugs by stopping treatment for a while. Evidence suggested that patients' HIV infections would revert to a drug-sensitive form.

Now a large clinical trial shows this doesn't happen. Drug-sensitive virus does indeed appear -- but that doesn't mean drug-resistant virus goes away. Patients who interrupt treatment don't suddenly do better. In fact, says researcher Jody Lawrence, MD, they do worse than those who continue treatment.

"Patients with HIV and multidrug-resistant virus should avoid STI," Lawrence tells WebMD. "In our study, those who remained on optimized standard treatment did better than those who tried STI."

Lawrence's report appears in the Aug. 28 issue of The New England Journal of Medicine.

Looking for New Options When Time Is Running Out

The study enrolled 270 patients who were running out of options. The HIV in their blood had developed resistance to all existing AIDS drugs. Even though they were getting the best possible treatment, there was more and more virus in their blood, and fewer and fewer life-preserving CD4 T cells.

"We embarked on this study because we are seeing more and more patients in this predicament," says Lawrence, a clinician at San Francisco General Hospital. "The patients are asking, 'Are these drugs doing me any good? Am I getting more harm from the drugs than good?' As a primary care provider, I didn't have any good answers."

In the study, half the patients continued with state-of-the-art therapy. In such patients, doctors keep testing the virus to see which drugs work best -- and continue giving them powerful combinations. Even in the face of mounting resistance, this works for a surprisingly long time -- but not forever. Eventually, AIDS appears.

That's why half the patients were willing to try something new. They stopped all AIDS drugs for four months. Drug-resistant HIV isn't as fit as drug-sensitive HIV. The hope was that once the drug-sensitive HIV returned, it would push out the drug-resistant form. Then drug treatment could begin again, with much more potent effect.

Today on WebMD

How much do you know?
contemplative man
What to do now.
Should you be tested?
HIV under microscope
What does it mean?
HIV AIDS Screening
man opening condom wrapper
HIV AIDS Treatment
Discrimination Stigma
Treatment Side Effects
grilled chicken and vegetables
obese man standing on scale
cold sore